Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 4/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8424903 | 1.00 | PNMT (0.38) | PNMTFFAR4ADRA2AFFAR1GRIN2B | |
| SCHEMBL8424902 | 1.00 | PNMT (0.38) | PNMTFFAR4ADRA2AFFAR1GRIN2B | |
| SCHEMBL8426665 | 0.84 | PNMT (0.41) | PNMTADRA2AGRIN2BMEN1KMT2A | |
| SCHEMBL7390944 | 0.81 | GRIN2B (0.41) | PNMTADRA2AGRIN2BMEN1KMT2A | |
| SCHEMBL10508397 | 0.81 | PNMT (0.48) | PNMTADRA2AGRIN2BMEN1KMT2A | |
| SCHEMBL16650443 | 0.81 | PNMT (0.46) | PNMTADRA2AGRIN2BMEN1KMT2A | |
| SCHEMBL8428904 | 0.81 | GRIN2B (0.38) | PNMTADRA2AGRIN2BMEN1KMT2A | |
| SCHEMBL8425949 | 0.80 | PNMT (0.36) | PNMTFFAR4ADRA2AFFAR1GRIN2B | |
| SCHEMBL8429563 | 0.78 | FFAR4 (0.39) | FFAR4FFAR1 | |
| SCHEMBL8425111 | 0.78 | FFAR4 (0.39) | FFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5925662-A | OXIDASE INHIBITORS | SYNTHELABO (FR) | 1999-07-20 | — | — | US | disclosed |